The Impact of Treatment-Free Remission of Tasigna® for Cml Patients in China – A Cost Effectiveness Analysis
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.221
https://www.valueinhealthjournal.com/article/S1098-3015(17)30555-7/fulltext
Title :
The Impact of Treatment-Free Remission of Tasigna® for Cml Patients in China – A Cost Effectiveness Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30555-7&doi=10.1016/j.jval.2017.08.221
First page :
A436
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
196